-
Product Insights
![]()
CSIS – Olympic City Integrated Housing Facilities – West Java
Equip yourself with the essential tools needed to make informed and profitable decisions with our CSIS - Olympic City Integrated Housing Facilities - West Java report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Company Profile
![]()
Computer Services Inc – Company Profile
Computer Services Inc (CSI) provides technology solutions for financial institutions and corporate entities. Its banking solutions include print and electronic distribution, digital banking, core processing, regulatory compliance, document delivery services and managed services, payments processing, internet and mobile banking and cloud-based managed services. The company also provides telecommunications services, cybersecurity, cloud-based managed services, network management, processing services, professional services, maintenance, support, software licensing, installation, e-business services and equipment and supply sales. Its customers include community and regional banks, multi-bank holding...
Add to Basket -
Company Profile
![]()
Ocular Therapeutix Inc – Company Profile
Ocular Therapeutix Inc (Ocular Therapeutix) is a biopharmaceutical company that discovers, develops and commercializes therapies for treating eye diseases. The company’s lead product candidate DEXTENZA is used for the treatment of post-surgical ocular inflammation and pain. Its pipeline products include OTX-TP, used for treating glaucoma and ocular hypertension, OTX-BPI, targeting acute ocular pain, OTX-BDI, against post-op pain, inflammation and anti-bacterial infections, OTX-KTO for treating allergic conjunctivitis, OTX-CSI, against dry eye. Ocular Therapeutix also develops intracameral implants for treating multiple eye...
Add to Basket -
Company Profile
![]()
comScore Inc – Company Profile
comScore Inc (CSI) is a provider of measuring consumer audiences and advertising across media platforms. The company offers independent data, metrics, products, and services to its clients. Its products and solutions include digital ad solutions and cross platform solutions. The company is an OTT offeror and distributor of streaming video content and also manages advertising agencies. CSI provides data information that combines information about content and advertising consumption on digital, television, and movie screens with demographics and other descriptive information....
Add to Basket -
Company Profile
![]()
Cardiovascular Systems Inc – Company Profile
Cardiovascular Systems Inc (CSI) is a medical device company that develops and commercializes products for the treatment of peripheral and coronary vascular disease. The company's products include peripheral orbital atherectomy system, coronary orbital atherectomy system, crowns, and accessories. Its peripheral artery disease system is a percutaneous orbital atherectomy system that is used as therapy for OAS atherosclerotic disease in peripheral arteries. CSI offers accessories such as guide wires, lubricants, infusion pumps and ancillary products. It has developed orbital atherectomy systems...
Add to Basket -
Product Insights
![]()
Cardiovascular Systems Inc Pipeline Insight and Competitive Landscape, 2023
Cardiovascular Systems Inc (CSI) is a medical device company that develops and commercializes products for the treatment of peripheral and coronary vascular disease. The company's products include peripheral orbital atherectomy system, coronary orbital atherectomy system, crowns, and accessories. Its peripheral artery disease system is a percutaneous orbital atherectomy system that is used as therapy for OAS atherosclerotic disease in peripheral arteries. CSI offers accessories such as guide wires, lubricants, infusion pumps and ancillary products. It has developed orbital atherectomy systems...
-
Company Profile
![]()
Hyundai Engineering & Construction Co Ltd – Company Profile
Hyundai Engineering & Construction Co Ltd (Hyundai E&C), a subsidiary of Hyundai Motor Co, is an engineering and construction contracting company. It provides civil and construction works for roads, bridges, harbors, highways, and railways. Hyundai E&C also develops properties for residential, commercial and office businesses. The company executes construction projects for nuclear power plants, power generation and industrial plants, and oil, gas, and petrochemical plants. Hyundai E&C offers services across total value chain of a project from design, finance, plan,...
Add to Basket -
Thematic Analysis
![]()
Cloud Computing in Banking – Thematic Intelligence
Cloud Computing in Banking Industry Thematic Overview The advantages of using cloud computing in banking industry are extensive. It helps companies to modernize infrastructure, scale operations, improve resiliency, reduce costs, and build new revenue streams and services. Cloud-based systems have helped banks adapt to the rise in remote working, increased customer app use, and associated security and fraud risks. The cloud computing in banking thematic intelligence report assesses how banking, combined with other emerging technologies, can be used across the...
-
Product Insights
![]()
Ocular Therapeutix Inc Pipeline Insight and Competitive Landscape, 2023
Ocular Therapeutix Inc (Ocular Therapeutix) is a biopharmaceutical company that discovers, develops and commercializes therapies for treating eye diseases. The company’s lead product candidate DEXTENZA is used for the treatment of post-surgical ocular inflammation and pain. Its pipeline products include OTX-TP, used for treating glaucoma and ocular hypertension; OTX-BPI, targeting acute ocular pain; OTX-BDI, against post-op pain, inflammation and anti-bacterial infections; OTX-KTO for treating allergic conjunctivitis; OTX-CSI, against dry eye. Ocular Therapeutix also develops intracameral implants for treating multiple eye...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – cyclosporine SR
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry cyclosporine SR Drug Details Cyclosporine (OTX-CSI) is under development for the treatment of chronic...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.